These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease. Gadel AA; Mostafa M; Younis A; Haleem M Hepatogastroenterology; 2012; 59(120):2498-502. PubMed ID: 23178615 [TBL] [Abstract][Full Text] [Related]
4. Association of gastroesophageal reflux disease risk with exacerbations of chronic obstructive pulmonary disease. Liang B; Wang M; Yi Q; Feng Y Dis Esophagus; 2013 Aug; 26(6):557-60. PubMed ID: 23301861 [TBL] [Abstract][Full Text] [Related]
5. Inhaled Beta Agonist Bronchodilator Does Not Affect Trans-diaphragmatic Pressure Gradient but Decreases Lower Esophageal Sphincter Retention Pressure in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Gastroesophageal Reflux Disease (GERD). Del Grande LM; Herbella FA; Bigatao AM; Jardim JR; Patti MG J Gastrointest Surg; 2016 Oct; 20(10):1679-82. PubMed ID: 27350150 [TBL] [Abstract][Full Text] [Related]
6. [Relationship between chronic obstructive pulmonary disease and gastroesophageal reflux disease defined by the Frequency Scale for the Symptoms of gastroesophageal reflux disease]. Takada K; Matsumoto S; Hiramatsu T; Kojima E; Iwata S; Shizu M; Okachi S; Ninomiya K; Morioka H Nihon Kokyuki Gakkai Zasshi; 2010 Sep; 48(9):644-8. PubMed ID: 20954364 [TBL] [Abstract][Full Text] [Related]
7. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108 [TBL] [Abstract][Full Text] [Related]
8. Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbation of chronic obstructive pulmonary disease during the first year following diagnosis--a nationwide population-based cohort study. Lin YH; Tsai CL; Chien LN; Chiou HY; Jeng C Int J Clin Pract; 2015 Mar; 69(3):350-7. PubMed ID: 25359162 [TBL] [Abstract][Full Text] [Related]
9. A systematic review with meta-analysis of gastroesophageal reflux disease and exacerbations of chronic obstructive pulmonary disease. Huang C; Liu Y; Shi G BMC Pulm Med; 2020 Jan; 20(1):2. PubMed ID: 31914979 [TBL] [Abstract][Full Text] [Related]
10. Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Liang BM; Feng YL Lung; 2012 Jun; 190(3):277-82. PubMed ID: 22258420 [TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux disease in COPD: links and risks. Lee AL; Goldstein RS Int J Chron Obstruct Pulmon Dis; 2015; 10():1935-49. PubMed ID: 26392769 [TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire. Takada K; Matsumoto S; Kojima E; Iwata S; Okachi S; Ninomiya K; Morioka H; Tanaka K; Enomoto Y Respir Med; 2011 Oct; 105(10):1531-6. PubMed ID: 21454063 [TBL] [Abstract][Full Text] [Related]
13. The Role of the Transdiaphragmatic Pressure Gradient (TGP) in the Pathophysiology of Proximal Reflux. Del Grande LM; Herbella FAM; Patti MG J Gastrointest Surg; 2021 Feb; 25(2):351-356. PubMed ID: 33443690 [TBL] [Abstract][Full Text] [Related]